Zheng Y. Jin

Chongqing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Decoding the tumor-aging axis: from bench to clinical.

Decoding the tumor-aging axis: from bench to clinical.

Journal: Frontiers in immunology

Published: March 05, 2026

Publisher Correction: SLC2A1+ tumour-associated macrophages spatially control CD8+ T cell function and drive resistance to immunotherapy in non-small-cell lung cancer.

Publisher Correction: SLC2A1+ tumour-associated macrophages spatially control CD8+ T cell function and drive resistance to immunotherapy in non-small-cell lung cancer.

Journal: Nature cell biology

Published: January 19, 2026

A conserved, terminal, pro-tumor neutrophil population.

A conserved, terminal, pro-tumor neutrophil population.

Journal: Cancer cell

Published: January 16, 2026

PIANet: a parallel interactive attention network for multi-channel PSG-based sleep staging.

PIANet: a parallel interactive attention network for multi-channel PSG-based sleep staging.

Journal: Biomedical physics & engineering express

Published: December 30, 2025

Tame the Hydra's head: Targeting bone marrow maladaptive myelopoiesis to reverse macrophage-mediated immunosuppression in cancer.

Tame the Hydra's head: Targeting bone marrow maladaptive myelopoiesis to reverse macrophage-mediated immunosuppression in cancer.

Journal: Immunity

Published: October 05, 2025

S100A8/A9 perturbation in bone marrow blunts antitumor immunity by promoting protumorigenic myelopoiesis in mouse models.

S100A8/A9 perturbation in bone marrow blunts antitumor immunity by promoting protumorigenic myelopoiesis in mouse models.

Journal: Science translational medicine

Published: July 16, 2025

SLC2A1+ tumour-associated macrophages spatially control CD8+ T cell function and drive resistance to immunotherapy in non-small-cell lung cancer.

SLC2A1+ tumour-associated macrophages spatially control CD8+ T cell function and drive resistance to immunotherapy in non-small-cell lung cancer.

Journal: Nature cell biology

Published: June 02, 2025

Deciphering cancer complexity: perspective on hematopoietic remodeling-mediated immunosuppression.

Deciphering cancer complexity: perspective on hematopoietic remodeling-mediated immunosuppression.

Journal: Oncogene

Published: January 02, 2025

DNASE1L3-expressing dendritic cells promote CD8+ T cell function and anti-PD-(L)1 therapy efficacy by degrading neutrophil extracellular traps.

DNASE1L3-expressing dendritic cells promote CD8+ T cell function and anti-PD-(L)1 therapy efficacy by degrading neutrophil extracellular traps.

Journal: Cancer cell

Published: November 12, 2024

Bone metastases diminish extraosseous response to checkpoint blockade immunotherapy through osteopontin-producing osteoclasts.

Bone metastases diminish extraosseous response to checkpoint blockade immunotherapy through osteopontin-producing osteoclasts.

Journal: Cancer cell

Published: June 30, 2024

Biological characteristics and clinical treatment of pulmonary sarcomatoid carcinoma: a narrative review.

Biological characteristics and clinical treatment of pulmonary sarcomatoid carcinoma: a narrative review.

Journal: Translational lung cancer research

Published: February 04, 2024

IFN-α/β/IFN-γ/IL-15 pathways identify GBP1-expressing tumors with an immune-responsive phenotype.

IFN-α/β/IFN-γ/IL-15 pathways identify GBP1-expressing tumors with an immune-responsive phenotype.

Journal: Clinical and experimental medicine

Published: January 24, 2024

Showing 1-12 of 53

Last Updated: 09/26/2026